Our team

Mission and Vision
About us
Pipeline
Partnering

Treeway is a clinical-stage biotechnology company with a mission to develop therapies to cure ALS and other neurodegenerative diseases. Founded in 2012 by two ALS patients, Treeway is committed to developing the neurodegenerative disease drugs of tomorrow. Currently, Treeway’s research and development’s pipeline consists of three programs for the ALS, Alzheimer’s disease and Ophtalmology indications. The ALS and Alzheimer’s disease programs are in clinical stage.

Treeway B.V.
Maidstone 48a
5026 SK Tilburg
The Netherlands
T: +31 135348272
E: info@treeway.nl
KvK: 56658044
VAT: NL852242086B01

Our Team
Careers
News
Contact